Bio-Thera Says China Approves BAT2306 Secukinumab Biosimilar
Bio-Thera Solutions announced that China’s NMPA approved BAT2306, which it describes as the first secukinumab biosimilar approved in China.
Bio-Thera Solutions announced that China’s NMPA approved BAT2306, which it describes as the first secukinumab biosimilar approved in China.